PERBELLINI, Omar
 Distribuzione geografica
Continente #
NA - Nord America 3.566
EU - Europa 3.294
AS - Asia 1.548
SA - Sud America 17
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 3
Totale 8.445
Nazione #
US - Stati Uniti d'America 3.534
GB - Regno Unito 1.291
CN - Cina 1.056
SE - Svezia 378
SG - Singapore 344
DE - Germania 342
FR - Francia 242
IE - Irlanda 236
IT - Italia 232
RU - Federazione Russa 205
FI - Finlandia 191
UA - Ucraina 57
BE - Belgio 40
NL - Olanda 33
TR - Turchia 27
CA - Canada 26
KR - Corea 24
IN - India 16
VN - Vietnam 15
IR - Iran 14
JP - Giappone 14
AU - Australia 10
ES - Italia 8
BR - Brasile 7
HK - Hong Kong 7
MX - Messico 6
RO - Romania 6
ID - Indonesia 5
NP - Nepal 5
CL - Cile 4
GR - Grecia 4
HU - Ungheria 4
PL - Polonia 4
AE - Emirati Arabi Uniti 3
EU - Europa 3
KZ - Kazakistan 3
PE - Perù 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
IQ - Iraq 2
LT - Lituania 2
LV - Lettonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
TG - Togo 2
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
DK - Danimarca 1
EC - Ecuador 1
GE - Georgia 1
HR - Croazia 1
IL - Israele 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
PK - Pakistan 1
TH - Thailandia 1
VE - Venezuela 1
Totale 8.445
Città #
Southend 1.149
Chandler 584
Jacksonville 456
Woodbridge 421
Ann Arbor 397
Singapore 295
Beijing 251
Dublin 236
Ashburn 234
New York 137
Wilmington 125
Houston 120
Jinan 94
Lawrence 87
Princeton 87
Nanjing 79
Verona 69
Shenyang 63
Tianjin 49
Helsinki 47
Hebei 45
Falls Church 40
Brussels 38
Haikou 35
Hangzhou 32
Ningbo 32
Nanchang 31
Boardman 30
Zhengzhou 29
Changsha 28
Guangzhou 24
Norwalk 24
Seoul 23
Groningen 21
Taiyuan 21
Milan 20
Sindelfingen 20
Los Angeles 19
Taizhou 18
Dearborn 17
Düsseldorf 16
Jiaxing 16
Nürnberg 16
Fuzhou 15
Dong Ket 13
Bologna 12
Lanzhou 12
Manchester 12
Redmond 12
Seattle 12
Kent 11
Redwood City 11
Santa Clara 11
Tokyo 10
Washington 10
Chicago 9
Moscow 9
Dallas 8
Lancaster 8
San Mateo 8
Auburn Hills 7
Toronto 7
Amsterdam 6
Ardabil 6
Augusta 6
Châtenay-Malabry 6
Enterprise 6
Leawood 6
Mestre 6
Munich 6
Paris 6
Cormano 5
Fremont 5
Parsa 5
Renton 5
Riva 5
Rome 5
San Francisco 5
Verdun 5
Zanjan 5
Arezzo 4
Costa Mesa 4
Fairfield 4
Jakarta 4
Monmouth Junction 4
Montreal 4
Newark 4
Pieve di Soligo 4
Qingdao 4
Stockholm 4
São Paulo 4
Athens 3
Baltimore 3
Cambridge 3
Changle 3
Clearwater 3
Colorno 3
Edinburgh 3
Hefei 3
Hong Kong 3
Totale 5.942
Nome #
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 368
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 225
DEATH RECEPTOR 3 EXPRESSION AND SERUM LEVEL OF SOLUBLE TL1A CORRELATE WITH INDOLENT, EARLY STAGE B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 160
NON-CANONICAL NOTCH SIGNALING IN T-ALL: A PHOSPHO-FLOW CYTOMETRY STUDY 150
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients 144
Analysis of B-cell receptor signal transduction in B-cell chronic lymphocytic leukemia by phosphospecific flow-cytometry 139
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 139
Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies 137
SINGLE-CELL PROFILES OF B-CELL RECEPTOR PHOSPHO-PROTEIN NETWORKS ASSOCIATED WITH PROGNOSIS AND PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA 128
EXPRESSION AND FUNCTIONAL ACTIVITY OF DEATH RECEPTOR 3 IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 122
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 122
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 121
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients. 121
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 121
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia 120
BCR-signaling profiles associated with prognosis and progression in B-CLL 118
Autoimmune complications are frequent in splenic and nodal marginal zone lymphomas 113
CXCL8 and interleukin-6 in B-cell chronic lymphocytic leukemia are up-reuglated through the activity of CXCL12 112
Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant 111
Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia 111
Underdiagnosed systemic mastocytosis: The role of flow cytometry 108
BCR-signaling profiles associated with prognosis and progression in B-CLL 108
METHODOLOGICAL APPROACH TO MINIMAL RESIDUAL DISEASE DETECTION BY FLOW CYTOMETRY IN ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA 108
IN VITRO STUDY OF THE MECHANISMS INVOLVED IN THE BONE MARROW MESENCHY- MAL STROMAL CELL MODULATORY EFFECT ON B CELL FUNCTIONS 108
THE COMBINATION OF SERUM THYMIDINE KINASE, B-2-MICROGLOBULIN AND SOLUBLE CD23 AT DIAGNOSIS IS PREDICTIVE FOR PROGRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA, INDEPENDENTLY FROM ZAP-70 EXPRESSION 106
Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow-derived mesenchymal stromal cells 105
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 105
A quantitative study on the growth variability of tumour cell clones in vitro 104
Human neutrophils interact with both 6-sulfo LacNAc+ DC and NK cells to amplify NK-derived IFN{gamma}: role of CD18, ICAM-1 and ICAM-3 104
Up-regulation of CXCL8/interleukin-8 production in response to CXCL12 in chronic lymphocytic leukemia 102
CXCL8/interleukin 8 in B-cell chronic lymphocytic leukemia is up-regulated through the activity of the CXCL12/CXCR4 axis 101
Somatic D816V KIT mutation in a case of adult-onset familial mastocytosis. 101
SIGNALING NETWORK IN T-CELL LYMPHOBLASTIC LEUKEMIA: RESULTS FROM A SINGLE-CELL MULTI-PARAMETRIC PHOSPHO-FLOW CYTOMETRY STUDY 98
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 97
Characterization of the cross-talk between human neutrophils and a subset of pro-inflammatory dendritic cells 96
Cross-talks within the innate immune system: the role of neutrophils 95
Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis 95
Flow cytometry analysis of B-cell receptor phospho-protein networks in chronic lymphocytic leukemia 95
EXPRESSION AND FUNCTIONAL ACTIVITY OF THE TNFR-SUPERFAMILY MEMBER DEATH RECEPTOR 3 IN CHRONIC LYMPHOCYTIC LEUKEMIA B CELLS ACTIVATED BY THE BCR 95
Integrated single cell network profiling data of ERK signaling and mutations of SF3B1 gene refine prognosis in chronic lymphocytic leukemia 95
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 95
Jagged-1, Jagged-2 and DLL-1 are the elements of Notch signaling mainly responsible for the antiapoptotic effect on B-lineage acute lymphoblastic leukemia exerted by bone marrow Mesenchymal Stem Cells 93
In Vitro Study Of The Mechanisms Involved In The Bone Marrow Mesenchymal Stromal Cell Modulatory Effect On B Cell Function 92
A simple score predicts clonal mast cell disorders in patients with systemic reactions to Hymenoptera venom without skin lesions 92
The TNF-Family Cytokine TL1A/Death Receptor 3 System Reduces Metabolic Activity in Chronic Lymphocytic Leukemia B Cells 90
Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients 90
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels 89
Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and hymenopteria allergy 88
Effects of wheat germ agglutinin on human gastrointestinal epithelium: insights from an experimental model of immune/epithelial cell interaction 88
THE TNF-FAMILY CYTOKINE TL1A/DEATH RECEPTOR 3 FUNCTIONAL AXIS MODULATES B- CELL CHRONIC LYMPHOCYTIC LEUKEMIA PROLIFERATION 88
The impact of sensitive KIT D816V detection on recognition of Indolent Systemic Mastocytosis 88
Human Bone marrow Mesenchymal Stem Cells protect B-cell Acute Lymphoblastic Leukemia from apoptosis in vitro by upregulation of Notch3 and Notch4 on both cell types 87
A Survey on Clinical and Biological Characteristic and Therapy Management of an Italian Series of 455 Adult Patients with Systemic Mastocytosis on Behalf of Italian Registry of Mastocytosis 87
Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels 86
ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients 86
Improved detection of the C-KIT D816V mutation using allele-specific arms real time PCR assay allows a finer recognition of patients with indolent systemic mastocytosis. 86
Adult T-cell acute lymphoblastic leukemia: prognostic impact of myeloid associated antigens. 85
Serum tryptase levels differently change over time in indolent systemic mastocytosis with or without skin lesions. 84
On the potential involvement of CD11d in co-stimulating the production of interferon-{gamma} by natural killer cells upon interaction with neutrophils via intercellular adhesion molecule-3 83
High incidence of autoimmune complications in 82 patients with non-MALT marginal zone lymphomas. 83
Interleukin 7 requirement for survival of T-cell acute lymphoblastic leukemia and human thymocytes on bone marrow stroma. 82
The combination of Serum Thymidine Kinase, Beta-2-Microglobulin and soluble CD23 at diagnosis is predictive for progression in B-cell Chronic Lymphocytic Leukemia, independently from ZAP-70 expression 81
Low catalase expression confers redox hypersensitivity and identifies an indolent clinical behavior in CLL 81
Notch-3 and Notch-4 signaling rescues from apoptosis Human B-lineage Acute Lymphoblastic Leukemia cells in contact with Human Bone marrow-derived Mesenchymal Stromal Cells 80
Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia 79
Flow-cytometric detection of minimal residual disease in adult acute lymphoblastic leukemia 78
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis 76
Neutrophil activation and survival are modulated by interaction with NK cells 75
Ultra-Deep Sequencing (UDS) Allows More Sensitive Detection of the D816V and Other Kit Gene Mutations in Systemic Mastocytosis 75
Outcome prediction by immunophenotypic minimal residual disease detection in adult T-cell acute lymphoblastic leukaemia 73
EPSTEIN-BARR VIRUS DNA LOAD IN CHRONIC LYMPHOCYTIC LEUKEMIA IS AN INDEPENDENT PREDICTOR OF CLINICAL COURSE AND SURVIVAL 73
Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival 73
Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells 72
null 70
On the co-purification of 6-sulfo LacNAc(+) dendritic cells (slanDC) with NK cells enriched from human blood. 66
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 64
Systemic Reactions After Hymenoptera Sting And Raised Serum Tryptase Strongly Suggest Clonal Mast Cells Disorders 63
Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome 61
Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases 60
null 55
A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasks 54
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia 48
Systemic mastocytosis associated with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Report of three cases 48
Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disorders 47
IDENTIFICATION AND CHARACTERIZATION OF CANDIDATE MYELOID DERIVED SUP- PRESSOR CELLS IN THE MONONUCLEAR FRACTION OF PERIPHERAL BLOOD SAMPLES FROM PATIENTS AFFECTED BY NON-HODGKIN LYMPHOMA (NHL), HODGKIN LYMPHOMA (HL), AND MULTIPLE MYELOMA (MM) 46
Multi-parametric phospho-flow cytometry in T-call Acute Lymphoblastic Leukemia 46
Rituximab, bendamustine and cytarabine (R-BAC) in patients with relapsed-refractory aggressive B-cell lymphoma 43
Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells 31
Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia 24
Bone marrow stromal cells up-regulate interleukin 8 production in human T-lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-κB and JNK/AP-1 pathways 21
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia 19
Totale 8.532
Categoria #
all - tutte 26.414
article - articoli 13.241
book - libri 0
conference - conferenze 13.173
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.828


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020688 0 0 0 0 85 118 94 73 38 108 80 92
2020/2021887 80 141 49 110 96 95 13 49 33 13 172 36
2021/2022872 86 257 5 83 68 33 20 48 40 23 60 149
2022/20231.667 103 192 134 320 135 403 17 99 206 13 33 12
2023/2024938 51 72 55 76 102 209 60 66 7 47 126 67
2024/2025728 95 149 85 342 57 0 0 0 0 0 0 0
Totale 8.532